BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 10, 2026
Home » Authors » Nuala Moran

Articles by Nuala Moran

UK Consolidation: Etiologics, Argenta Plan For £12M Merger

Oct. 5, 2004
By Nuala Moran

UK Consolidation: Etiologics, Argenta Plan For £12M Merger

Oct. 5, 2004
By Nuala Moran

Physiomics Enters Deal With Bayer, Eyes IPO On AIM Index

Sep. 29, 2004
By Nuala Moran

Physiomics Enters Deal With Bayer, Eyes IPO On AIM Index

Sep. 29, 2004
By Nuala Moran

CeNeS Reports Positive Phase III M6G Data In Post-Operative Pain

Sep. 22, 2004
By Nuala Moran

Acambis Falls On Cancelled Smallpox Contract From CDC

Sep. 22, 2004
By Nuala Moran

CeNeS Reports Positive Phase III M6G Data In Post-Operative Pain

Sep. 22, 2004
By Nuala Moran

Acambis Falls On Cancelled Smallpox Contract From CDC

Sep. 22, 2004
By Nuala Moran

Acambis Falls On Cancelled Smallpox Contract From CDC

Sep. 21, 2004
By Nuala Moran

Acambis Falls On Cancelled Smallpox Contract From CDC

Sep. 21, 2004
By Nuala Moran
Previous 1 2 … 443 444 445 446 447 448 449 450 451 … 537 538 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing